1.Antidepressant effects of capsaicin in rats with chronic unpredictable mild stress-induced depression
Jae Ock LIM ; Min Ji KIM ; Jun Beom BAE ; Chan Hyeok JEON ; Jae Hyeon HAN ; Tae Hyeok SIM ; Youn Jung KIM
Journal of Korean Biological Nursing Science 2023;25(1):43-54
Purpose:
This study was conducted to assess the antidepressant effects of capsaicin in chronic depressive rats and elucidate the mechanism underlying its effects.
Methods:
Male Wistar rats (280~320 g, 8 weeks of age) were subjected to depression induced by chronic unpredictable mild stresses. The rats were exposed to 8 kinds of stresses for 8 weeks. In the last 2 weeks, fluoxetine or capsaicin was injected subcutaneously. The dose of fluoxetine was 10 mg/kg (body weight), while the doses of capsaicin consisted of low (1 mg/kg), middle (5 mg/kg), and high (10 mg/kg). The forced swim test (FST) was conducted to evaluate the immobility time of rats. The immobility time indicates despair, one of symptoms of depression. The change of tryptophan hydroxylase (TPH) in the dorsal raphe was investigated using immunohistochemistry. In the hippocampus cornu ammonis (CA) 1 and 3, glucocorticoid receptor (GR) expression was measured.
Results:
The immobility time in the FST was significantly lower (p < .05) in the low-dose (M = 32.40 ± 13.41 seconds) and middle-dose (M = 28.48 ± 19.57 seconds) groups than in the non-treated depressive rats (M = 90.19 ± 45.34 seconds). The amount of TPH in the dorsal raphe was significantly higher (p < .05) in the middle-dose (M = 249.17 ± 35.02) and high-dose (M = 251.0 ± 56.85) groups than in the non-treated depressive rats (M = 159.78 ± 41.16). However, GR expression in the hippocampus CA1 and CA3 did not show significant differences between the non-treated depressive rats and the capsaicin-injected rats.
Conclusion
This study suggests that capsaicin produces an antidepressant-like effect on chronic unpredictable mild stress-induced depression in rats via the serotonin biosynthesis pathway.
2.Effects of Epidural Naloxone on Pruritus Induced by Hydromorphone Epidural Patient-Controlled Analgesia.
Si Ra BANG ; Hee Suk KIM ; Ji Hyeok KIM ; Woo Seok SIM ; Mi Sook GWAK ; Mi Kyung YANG ; Chung Su KIM ; Tae Soo HAHM ; Hyun Sung CHO ; Duck Hwan CHOI ; Tae Hyeong KIM
The Korean Journal of Pain 2006;19(1):91-95
BACKGROUND: Opioid delivered by epidural patient-controlled analgesia (PCA) is effective in relieving pain after surgery, but it is associated with side effects, such as nausea, vomiting, pruritus, respiratory depression, and urinary retention. The purpose of this study was to compare hydromorphone related side effects and the quality of analgesia when naloxone was added to epidural PCA regimen. METHODS: Fifty-two thoracotomy patients with PCA were allocated blindly into two groups. Patients in group H (n = 26) received continuous epidural hydromorphone (16microgram/ml) in 0.1% bupivacaine; patients in group N (n = 26) received an epidural infusion containing naloxone (2 microgram/ml) and hydromorphone (16microgram/ml) in 0.1% bupivacaine. The basal rate of PCA was 4 ml/hr and the demand dose was 1.5 ml with a lockout time of 15 min. Pain intensity, sedation, pruritus, nausea and vomiting, respiratory depression were checked at 6, 12, 24 hours postoperatively. RESULTS: The Visual Analog Scale (VAS) scores were significantly lower in group H than in group N. There were no significant differences in the overall incidence of pruritus, nausea and sedation between the two groups. CONCLUSIONS: Continuous epidural infusion of naloxone combined with hydromorpho-ne is not effective in reducing the incidence and severity of pruritus induced by epidural hydromorphone.
Analgesia
;
Analgesia, Patient-Controlled*
;
Bupivacaine
;
Humans
;
Hydromorphone*
;
Incidence
;
Naloxone*
;
Nausea
;
Passive Cutaneous Anaphylaxis
;
Pruritus*
;
Respiratory Insufficiency
;
Thoracotomy
;
Urinary Retention
;
Visual Analog Scale
;
Vomiting
3.Effect of Low Dose 5-Fluorouracil and Cisplatin Intra-arterial Infusion Chemotherapy in Advanced Hepatocellular Carcinoma with Decompensated Cirrhosis.
Tae Young LIM ; Jae Youn CHEONG ; Sung Won CHO ; Sung Jun SIM ; Jong Su KIM ; Sung Jun CHOI ; Jeong Woo CHOI ; Hyeok Choon KWON ; Kee Myung LEE ; Jai Keun KIM ; Je Hwan WON ; Byung Moo YOO ; Kwang Jae LEE ; Ki Baik HAHM ; Jin Hong KIM
The Korean Journal of Hepatology 2006;12(1):65-73
BACKGROUND/AIMS: Advanced hepatocellular carcinoma (HCC) with portal vein thrombosis (PVT) has a poor prognosis. The aim of this study was to evaluate the efficacy and safety of repeated arterial infusions of low dose cisplatin and 5-fluorouracil (FU) in patients with advanced HCC with decompensated cirrhosis. METHODS: Between January 1995 and December 2003, a total of 79 decompensated cirrhotic patients having HCC and PVT were enrolled and divided into 2 groups. Group 1 (n=40) received intra-arterial infusion chemotherapy with cisplatin (10 mg for 5 days) and 5-FU (250 mg for 5 days) via an implanted chemoport every 4 weeks' and group 2 (n=39) was managed with only conservative treatment. RESULTS: The two groups were well matched with respect to the features relating to the prognosis, including age, gender and the Child- Pugh class. Although diffuse tumor involvement, main portal vein tumor thrombosis and bi-lobar involvement were more frequent in group 1, the median survival period of group 1 was significantly longer than group 2 (5 months vs. 3 months, respectively, P=0.016). Also, the 1-year survival rate of group 1 (7.5%) was higher than that of group 2 (5.1%) (P=0.016). When we analyzed the patients with the Child class B, the survival benefits of intra-arterial chemotherapy were more significant (P=0.008). CONCLUSIONS: Intra-arterial chemotherapy consisting of low dose 5-FU and cisplatin achieved favorable results for advanced HCC patients who had decompensated cirrhosis, and it showed better survival in selected patients. This therapy may be useful as a palliative treatment for HCC patients with decompensated cirrhosis.
Venous Thrombosis/complications
;
Survival Rate
;
Portal Vein
;
Palliative Care
;
Middle Aged
;
Male
;
Liver Neoplasms/complications/*drug therapy/mortality
;
Liver Cirrhosis/complications
;
*Infusions, Intra-Arterial
;
Humans
;
Fluorouracil/administration & dosage
;
Female
;
Disease-Free Survival
;
Cisplatin/administration & dosage
;
Carcinoma, Hepatocellular/complications/*drug therapy/mortality
;
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
;
Aged
;
Adult